AP source: US to buy additional 100M J&J doses
This Dec. 2, 2020 photo provided by Johnson & Johnson shows vials of the Janssen COVID-19 vaccine in the United States. Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday, Feb. 24, 2021, that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.[Johnson & Johnson via AP]
President Joe Biden is announcing Wednesday the U.S. is buying an additional 100 million doses of the single-shot Johnson & Johnson coronavirus vaccine.
The drugmaker is already obligated to supply 100 million doses to the federal government by the end of June. The additional vaccine would be delivered in the months following.
A White House official previewed the news on the condition of anonymity before the president’s remarks.
The U.S. is set to receive enough doses of the three approved vaccines by the middle of May to cover all adults. The surplus would ensure supply to cover young adults and children, pending the result of safety and efficacy trials. They could also be used as potential "boosters" to further protect against emerging virus variants, or be shared with allies overseas once Americans are protected.
KSTP’s complete COVID-19 coverage